Safety question
Is Rapamycin safe?
Use with caution — established risks require monitoring. Rapamycin scores 2/5. Cardiovascular, neurological, or psychiatric adverse events appear in the clinical record. Not appropriate for casual or untracked use. Coordinate with a clinician, particularly if you have any cardiovascular, hepatic, or psychiatric history.
Safety score
2 / 5
Evidence grade
A
Severe reactions on file
1
Pubmed cites
36000
Key facts
- typical dose
- 5–10 mg
- dose frequency
- weekly (longevity protocols)
- timing
- AM
- with food
- optional
- safety score
- 2/5
- evidence grade
- A
- class
- neuroprotective
- PubMed citations
- 36000
- legal status (US)
- Prescription-only
- legal status (UK)
- Prescription-only
- legal status (EU)
- Prescription-only
- legal status (AU)
- Prescription-only
- primary mechanism
- Selective inhibitor of mTORC1 (mechanistic target of rapamycin complex 1), reducing protein synthesis and inducing autophagy.
Common side effects
- Immunosuppressionsevere
- Mouth ulcersmoderate
- Hyperlipidemiamoderate
- Glucose intolerancemoderate
Severe reaction risks
Rapamycin has the following documented severe adverse reactions: Immunosuppression. These are rare but require immediate medical attention if they occur.
Who should not take Rapamycin
- Pregnant or breastfeeding individuals — most nootropics have not been adequately studied in pregnancy, and the precautionary principle applies.
- Anyone on a prescription medication that overlaps mechanistically (stimulants, SSRIs, MAOIs, beta-blockers, anticoagulants) — clear interactions with your prescribing clinician before adding Rapamycin.
- Anyone with significant cardiovascular, hepatic, renal, or psychiatric disease — established conditions raise the baseline risk for any new compound.
- Minors — almost no nootropics have a paediatric safety record, and developing brains are differently sensitive.
What "safe" means here
Our safety scoring reflects (a) published clinical and observational literature on healthy-adult use at standard supplement doses, (b) the spectrum of adverse-event reports in the medical and supplement-pharmacovigilance record, and (c) the regulatory status across major jurisdictions. It does notreflect long-term outcomes in populations that haven’t been studied, and it does not substitute for clinical judgement applied to your individual situation.
A 5/5 score does not mean “no risk” — it means risk has been quantified as low in healthy adults at usual doses. Idiosyncratic and allergic reactions are possible with virtually any compound, including those we rate highest.
Full mechanism, citations, and dose guidance for Rapamycin are on the main reference page — see Rapamycin. For the dose-by-dose breakdown, see Rapamycin dosage. To check stack interactions, use the interaction checker.
This page is informational. It is not medical advice and does not establish a clinician-patient relationship. Individual risk varies with genetics, medications, pre-existing conditions, and dose. Always consult a qualified clinician before starting a new compound. See our full disclaimer and terms.